Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 233 | $30,838,650 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Mar 2024 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 05 Mar 2024 | Sale | 20,054 | 12.0577 | 241,805 | D |
21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 19,745 | 12.3117 | 243,095 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 28,704 | 8.47 | 243,123 | D |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Feb 2024 | Sale | 25,000 | 9.8624 | 246,560 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 17,227 | 14.344 | 247,104 | D |
15 Jun 2023 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2023 | Sale | 25,000 | 9.9323 | 248,308 | D |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 23,933 | 10.4335 | 249,705 | D |
15 Jun 2023 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Jun 2023 | Sale | 25,000 | 10.0735 | 251,837 | D |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 25,000 | 10.1 | 252,500 | I |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Jan 2024 | Sale | 25,000 | 10.2539 | 256,348 | D |
14 Feb 2023 16:10 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 13 Feb 2023 | Purchase | 32,474 | 7.9706 | 258,837 | I |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Jan 2024 | Sale | 25,000 | 10.4464 | 261,160 | D |
14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Mar 2024 | Sale | 25,000 | 10.455 | 261,375 | D |
07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Apr 2023 | Sale | 40,000 | 6.6418 | 265,672 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 24,302 | 11.2501 | 273,400 | D |
27 Jul 2023 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 25 Jul 2023 | Sale | 18,719 | 14.6089 | 273,464 | D |
14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Mar 2024 | Sale | 25,000 | 11.0326 | 275,815 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 25 Jul 2023 | Sale | 20,000 | 14.3 | 286,000 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 26 Jul 2023 | Sale | 20,000 | 14.41 | 288,200 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 30,853 | 9.4903 | 292,804 | D |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 33,765 | 8.7835 | 296,575 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 24,500 | 13.6236 | 333,778 | D |
17 Feb 2023 17:27 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 16 Feb 2023 | Purchase | 42,682 | 7.8966 | 337,043 | I |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jul 2023 | Sale | 30,000 | 11.72 | 351,600 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 40,000 | 8.84 | 353,600 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 40,000 | 9.02 | 360,800 | D |
17 Aug 2022 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Aug 2022 | Sale | 30,000 | 12.6148 | 378,444 | D |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 28,038 | 13.65 | 382,719 | I |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 May 2024 | Sale | 50,000 | 7.73 | 386,500 | D |
02 Mar 2023 16:05 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 01 Mar 2023 | Purchase | 48,867 | 7.9416 | 388,082 | I |
23 Feb 2023 16:26 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 22 Feb 2023 | Purchase | 50,941 | 7.8329 | 399,016 | I |
28 Feb 2023 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 27 Feb 2023 | Purchase | 52,500 | 7.69 | 403,725 | I |
24 Feb 2023 16:08 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 23 Feb 2023 | Purchase | 51,864 | 7.7856 | 403,792 | I |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 40,000 | 10.1 | 404,000 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 18 Jul 2023 | Sale | 30,000 | 13.74 | 412,200 | D |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jun 2024 | Sale | 50,000 | 8.42 | 421,000 | D |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 36,319 | 11.8583 | 430,682 | D |
06 Oct 2023 18:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Oct 2023 | Sale | 59,794 | 7.2085 | 431,025 | D |
09 Feb 2024 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Feb 2024 | Sale | 48,272 | 9.2182 | 444,981 | D |
08 Dec 2023 17:22 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Dec 2023 | Sale | 59,829 | 7.4946 | 448,394 | D |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Jun 2024 | Sale | 50,000 | 9 | 450,000 | D |
21 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 17 Feb 2023 | Purchase | 63,382 | 7.7149 | 488,986 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 06 Jan 2023 | Purchase | 68,953 | 7.4052 | 510,611 | I |
09 Jun 2023 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jun 2023 | Sale | 56,436 | 9.0511 | 510,808 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 28 Dec 2022 | Purchase | 71,299 | 7.1796 | 511,898 | I |
03 Mar 2023 16:09 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 02 Mar 2023 | Purchase | 66,822 | 7.8171 | 522,354 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 10 Jan 2023 | Purchase | 69,518 | 7.7224 | 536,846 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 70,890 | 8.096 | 573,925 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 09 Jan 2023 | Purchase | 76,046 | 7.638 | 580,839 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 05 Jan 2023 | Purchase | 80,035 | 7.3787 | 590,554 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 29 Dec 2022 | Purchase | 84,622 | 7.714 | 652,774 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 04 Jan 2023 | Purchase | 91,892 | 7.8013 | 716,877 | I |
22 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 21 Feb 2023 | Purchase | 94,418 | 7.7435 | 731,126 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 30 Dec 2022 | Purchase | 99,754 | 7.5548 | 753,622 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 23 Dec 2022 | Purchase | 100,378 | 7.5158 | 754,421 | I |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 60,955 | 13.0171 | 793,457 | D |
27 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 24 Feb 2023 | Purchase | 109,118 | 7.639 | 833,552 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 78,071 | 12.1465 | 948,289 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 27 Dec 2022 | Purchase | 145,652 | 7.2392 | 1,054,404 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 03 Jan 2023 | Purchase | 141,646 | 7.5047 | 1,063,011 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)